Skip to main content

Closed

MRKR: Marker Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-590.0%

ROIC-89.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.79×

Marker Therapeutics, Inc.

MRKRNASDAQ Capital Market·USD·Closed

Marker Therapeutics, Inc.

MRKRNASDAQ·USD·Closed

$1.13

+0.89%

$1.13

+$0.01 (0.89%)

52W Range

19thpctl

Volume

0.61×avg

Mkt Cap

12.20MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

19thpctl

Volume

0.61×avg

Market Cap

12.20MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings